Overview

Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan

Status:
Completed
Trial end date:
2017-07-24
Target enrollment:
Participant gender:
Summary
Every lunar year, during the month of Ramadan, Muslims abstain from food and drink between dawn and nightfall. People with type 2 diabetes who fast during Ramadan are at an increased risk of acute glycemic complications. Our aim is to investigate the effect of dosage reduction of four glucose-lowering multidrug regimens on the incidence of acute glycemic complications in people with type 2 diabetes who fast during Ramadan.
Phase:
Phase 4
Details
Lead Sponsor:
University of Jordan
Treatments:
Glimepiride
Insulin
Insulin Glargine
Insulin, Globin Zinc
Metformin
Vildagliptin